ADMA Biologics Inc (ADMA) Stock Price Today
Aura AI Summary
Key Stats
- $2.28BMarket Cap
- 2,100,139Volume
- HealthSector
- $20.3852W High
- $7.6052W Low
- 17 DaysTypical Hold Time
- $2.35BEnterprise Value
- -Div Yield
- 98% Sell | 2% BuyTrading Activity
Track ADMA Biologics Inc (ADMA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.6 and a high of $20.38, highlighting its annual price range. Buy and sell ADMA Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Most Recent News
MMR vaccines now available at 530+ CVS locations in New York amid measles outbreak
In response to a measles outbreak and statewide emergency in New York, CVS Health is offering measles-mumps-rubella (MMR) vaccinations at over 530 CVS Pharmacy locations and MinuteClinic sites across the state. The MMR vaccine is crucial to prevent t...

Best Eli Lilly stock buys were during crises, not at hype peaks of Mounjaro and Zepbound drug approvals.
Eli Lilly's most profitable stock entry points were during less hyped events like the 2008 ImClone acquisition and the 2014 Trulicity approval, yielding returns over 2,000%. In contrast, buying at the peaks of hype around blockbuster drugs Mounjaro a...

Deutsche Bank maintains 'sell' on Travis Perkins amid weak UK construction demand.
Deutsche Bank has reaffirmed its 'sell' rating on Travis Perkins with a target price of 550p, slightly below the current 572.5p share price. The bank highlights ongoing weakness in the UK construction market, noting a 10% drop in brick deliveries in ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.